Neoadjuvant Therapy of DOF Regimen Plus Bevacizumab Can Increase Surgical Resection Ratein Locally Advanced Gastric Cancer: A Randomized, Controlled Study

Locally advanced gastric cancer (LAGC) is best treated with surgical resection. Bevacizumab in combination with chemotherapy has shown promising results in treating advanced gastric cancer. This study aimed to investigate the efficacy of neoadjuvant chemotherapy using the docetaxel/oxaliplatin/5-FU...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Junxun, Yao, Sheng, Li, Xiao-Song, Kang, Huan-Rong, Yao, Fang-Fang, Du, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620807/
https://www.ncbi.nlm.nih.gov/pubmed/26496252
http://dx.doi.org/10.1097/MD.0000000000001489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620807/
https://www.ncbi.nlm.nih.gov/pubmed/26496252
http://dx.doi.org/10.1097/MD.0000000000001489

Ejemplares similares